Cambridge Investment Research Advisors’s ArcBest ARCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,734
Closed -$270K 3140
2023
Q2
$270K Buy
2,734
+12
+0.4% +$1.07K ﹤0.01% 2623
2023
Q1
$252K Buy
+2,722
New +$245K ﹤0.01% 2630
2022
Q2
Sell
-2,737
Closed -$220K 3051
2022
Q1
$220K Buy
2,737
+314
+13% +$28.3K ﹤0.01% 2796
2021
Q4
$290K Buy
+2,423
New +$247K ﹤0.01% 2554
2019
Q2
Sell
-19,215
Closed -$592K 2210
2019
Q1
$592K Sell
19,215
-158
-0.8% -$5.7K 0.01% 1373
2018
Q4
$664K Buy
19,373
+1,152
+6% +$44.6K 0.01% 1163
2018
Q3
$885K Sell
18,221
-4,806
-21% -$226K 0.01% 1094
2018
Q2
$1.05M Sell
23,027
-473
-2% -$19.5K 0.01% 941
2018
Q1
$753K Sell
23,500
-283
-1% -$9.86K 0.01% 1103
2017
Q4
$850K Buy
23,783
+1,493
+7% +$50.9K 0.01% 984
2017
Q3
$746K Buy
+22,290
New +$587K 0.01% 994
2017
Q2
Sell
-11,194
Closed -$291K 1932
2017
Q1
$291K Buy
+11,194
New +$329K 0.01% 1403

Other funds holding ARCB

Cambridge Investment Research Advisors's ARCB Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of ArcBest (ARCB) in Q3 2023, closing a stake of 2,734 shares — an estimated $270K sold.

Cambridge Investment Research Advisors first reported a position in ARCB in Q1 2017 and held it in 12 quarters. The position peaked at $1.05M in Q2 2018. 277 funds tracked by Wall St. Rank hold ARCB as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining ArcBest position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,734 ArcBest shares in Q3 2023, an estimated $270K.
  • Cambridge Investment Research Advisors first reported a position in ArcBest in Q1 2017 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's ArcBest position peaked at $1.05M in Q2 2018.
  • 277 funds tracked by Wall St. Rank held ArcBest as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.